New research published in Genome Medicine examines neoepitopes, new versions of proteins or peptides that can be produced following cancer-specific mutations.… Read more »
Ti-Cheng Chang is a bioinformatics research scientist at St. Jude Children's Research Hospital. The driving forces behind his research are developing computational genomics methods and applying them to understand disease etiology. Currently he has particular interests in identifying cancer antigens associated with tumor destruction, and elaborating the contribution of these cancer antigens to tumor immunogenicity.The long-term goal is to exploit these antigens for cancer immunotherapy.
Latest posts by Ti-Cheng Chang (see all)
- Neoepitopes – new targets for childhood cancer therapy - 6th September 2017